KIT and breast leiomyosarcoma: Histopathological analysis confirmed metastatic breast leiomyosarcoma, supported by characteristic immunohistochemical profile: positive for smooth muscle actin (SMA), cluster of differentiation (CD) 34, and CD10, negative for Desmin and CD117, and with a low proliferative index (Ki-67 5-10%).